Weigh the Benefits and Risks of Vyvanse in Binge-Eating Patients

Vyvanse (lisdexamfetamine) is now approved for moderate to severe binge eating disorder in adults.....

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote